HIV prevention injections run out within days in Uganda
By the AFREEQUE newsroom, based on The Independent

Uganda’s Ministry of Health reports that doses of lenacapavir, an HIV prevention injection administered twice a year, are being used up within days at health facilities. HIV prevention coordinator Peter Mudiope says demand has exceeded expectations, with some patients who had refused oral PrEP now requesting the injection, according to The Independent Uganda.
Uganda’s Ministry of Health confirms that doses of lenacapavir, a preventive HIV injection administered twice a year, run out within days of arriving at health facilities. This demand is putting pressure on limited supplies in Uganda and neighbouring Kenya.
Peter Mudiope, the ministry’s HIV prevention coordinator, says the response to the new product has exceeded initial expectations. When it was launched on 17 April, one facility had only 20 doses, which were quickly used up, and doses had to be reserved for the following six months. The ministry initially targeted users of oral pre-exposure prophylaxis (PrEP) who wanted a more convenient alternative; however, some people who had refused all other forms of prevention are now turning to the injection. The ministry has therefore had to present the product as one option among several.
Uganda has 103 facilities offering lenacapavir, and additional deliveries are expected in December to expand access. Mr Mudiope made these statements during a regional webinar on access to lenacapavir in Kenya, Malawi and Uganda. He acknowledged that demand remains high, particularly among those who prefer the twice-yearly injection, and said the product is attracting new PrEP users.
In the region, Rwanda is due to launch a six-month HIV prevention injection on 1 December.



